MeenakshiCPatelMD

Geriatrics • Centerville, OH

Hospice and Palliative Medicine

Physician

Join to view full profile

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Patel's full profile

Already have an account?

Office
6611 Clyo Rd Ste E
Centerville, OH 45440
Phone+1 937-208-8282

Fax+1 937-208-8276
Is this information wrong?

Education & Training

Sinai Hospital of BaltimoreResidency, Internal Medicine, 1983 - 1986
Seth G.S. Medical CollegeClass of 1981, M.B.B.S

Certifications & Licensure

OH State Medical License 1986 - 2026
MD State Medical License 1985 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Geriatric Medicine
American Board of Internal Medicine Hospice and Palliative Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
Completed
Phase 2, Phase 3
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology Start of enrollment: 2013 Jun 01
Unknown status
Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
18F-AV-1451 Autopsy Study Start of enrollment: 2015 Sep 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

13 citations
INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML I...
Munshi, M. N., Munshi, M. N., Gill, J., Gill, J., Chao, J., Chao, J., Nikonova, E. V., Nikonova, E. V., Patel, M., Patel, M.> ;Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2017 Nov 7

Press Mentions

Local Physicians, Medical Students Gather for Moment of SilenceJune 6th, 2020